In women, due to the combination of a high prevalence of cancers at a young age, and cardiovascular diseases at an older age, the effect of BRCA1&2-mutations on cardiovascular morbidity and mortality is difficult to evaluate. This evidence concerns the gene BRCA1 and cardiovascular disorder.